The 20 Best Lung Transplant Doctors in Maryland, US

Errol L. Bush, M.D., FACS, is a thoracic surgeon and surgical director of the Advanced Lung Disease and Lung Transplant Program for the Johns Hopkins Comprehensive Transplant Center. He also serves as director of the Ex vivo Lung Perfusion Program (EVLP). Dr. Bush specializes in the surgical treatment of chronic and end stage lung diseases, as well as benign (non-cancerous) and malignant (cancerous) diseases and lesions of the chest. He is skilled in minimally invasive operations such as video-assisted thoracoscopic surgery (VATS), a type of thoracic surgery performed using a small video camera that is introduced into the patient's chest via a scope to treat lung and esophageal cancers. Dr. Bush also has experience with extracorporeal membrane oxygenation (ECMO), a technique of providing both cardiac and respiratory support oxygen to patients whose heart and lungs can no longer serve their function. His research interests include investigations of outcomes and health disparities related to lung cancer, lung transplant and ECMO patients. Dr. Bush is currently leading several open clinical trials. Dr. Bush is rated as an Elite provider by MediFind in Lung Transplant. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pulmonary Fibrosis, Collapsed Lung, Lung Transplant, and Heart Transplant. Dr. Bush is board certified in American Board Of Thoracic Surgery and American Board Of Surgery.

Dr. Merlo is an internist who specializes in pulmonary and critical care medicine. Dr. Merlo also has clinical expertise in the care of patients with cystic fibrosis as well as clinical expertise in the care of patients with advanced lung disease who may require or have undergone lung transplantation. Dr. Merlo holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Merlo attended the College of the Holy Cross and completed medical school and residency training in internal medicine at Georgetown University. He completed both clinical and research fellowships in pulmonary and critical care medicine at Johns Hopkins, and earned his M.P.H. at the Bloomberg School of Public Health. His research interests include outcomes in lung transplantation and cystic fibrosis, HIV-related pulmonary disease, and outcomes in Osler Weber Rendu. Dr. Merlo serves as the Associate Program Director of Scholarship for the Osler Medical Housestaff Training Program. He has contributed numerous scientific papers and book chapters related to cystic fibrosis and lung transplantation, and his awards include the Harry Shwachman Clinical Investigator Award from the Cystic Fibrosis Foundation. Dr. Merlo is rated as an Elite provider by MediFind in Lung Transplant. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Aspergillosis, Lung Transplant, and Endoscopy.

Dr. Jonathan Orens is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pulmonary and critical care medicine. He is an internationally recognized expert in lung transplantation. Dr. Orens received his M.D. from the University of Maryland School of Medicine. He completed his residency at the University of Maryland Medical Center and performed a fellowship in pulmonary and critical care medicine at the University of Michigan Hospitals. Dr. Orens joined the Johns Hopkins faculty in 1998. His research interests include clinical outcomes of lung transplantation, chronic allograft rejection and ischemic reperfusion injury. Dr. Orens is rated as an Elite provider by MediFind in Lung Transplant. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Cystic Fibrosis, Secondary Immunodeficiency (SID), Lung Transplant, and Endoscopy. Dr. Orens is board certified in American Board Of Internal Medicine.

Dr. Sean Agbor-Enoh is an instructor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pulmonary and critical care medicine. He received his M.D. from the University of Cameroon. He completed his residency at Johns Hopkins Bayview Medical Center and performed a fellowship in pulmonary medicine at Johns Hopkins. Dr. Agbor is rated as an Elite provider by MediFind in Lung Transplant. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Cystic Fibrosis, Pneumonia, Bronchiolitis Obliterans, Lung Transplant, and Tissue Biopsy. Dr. Agbor is board certified in American Board Of Internal Medicine.

Alexander Krupnick is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Krupnick is rated as an Elite provider by MediFind in Lung Transplant. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pulmonary Fibrosis, Lung Transplant, and Gastrostomy.

Dr. Pali Dedhiya Shah is a pulmonary and critical care physician. She is an expert in the diagnosis and treatment of advanced lung disease and lung transplantation. She is the medical director of the Johns Hopkins Lung Transplant program. She is a member of the International Society for Heart and Lung transplantation and provides teaching to medical students, residents and fellows at Johns Hopkins. Dr. Shah earned her medical degree from Jefferson Medical College of Thomas Jefferson University. She completed her residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Shah joined the Johns Hopkins faculty as an assistant professor of medicine in 2011. Dr. Shah is rated as a Distinguished provider by MediFind in Lung Transplant. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Lung Metastases, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Jinny Ha is a Thoracic Surgeon practicing medicine in Baltimore, Maryland. Dr. Ha is rated as a Distinguished provider by MediFind in Lung Transplant. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Lung Nodules, Pleuropulmonary Blastoma, Lung Cancer, Lung Transplant, and Osteotomy. Dr. Ha is board certified in American Board Of Thoracic Surgery and American Board Of Surgery.

Robert Reed is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Reed is rated as a Distinguished provider by MediFind in Lung Transplant. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Acute Interstitial Pneumonia, Lung Transplant, and Endoscopy.

Alfred Casillan is a Thoracic Surgeon practicing medicine in Baltimore, Maryland. Dr. Casillan is rated as a Distinguished provider by MediFind in Lung Transplant. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Lymphangioleiomyomatosis, Lung Transplant, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Casillan is board certified in American Board Of Thoracic Surgery.

Roy Brower is a Professor of Medicine at Johns Hopkins University and was Medical Director of the Medical Intensive Care Unit at Johns Hopkins Hospital for over 30 years. He obtained his M.D. degree and completed his residency and fellowship in Pulmonary and Critical Care Medicine at Johns Hopkins. Brower’s earlier research explored mechanisms of cardiopulmonary interactions and pulmonary circulation physiology. He subsequently focused research efforts in the clinical venue. Brower has led four multicenter clinical trials of lung-protective mechanical ventilation strategies in patients with the acute respiratory distress syndrome (ARDS). One of these trials demonstrated substantially improved clinical outcomes in ARDS patients who received mechanical ventilation with lower tidal volumes. Brower was a member of the NIH ARDS Network from its inception in 1994. He was the Chair of the Steering Committee of the NIH Prevention and Early Treatment of Acute Lung Injury (PETAL) Network from 2014 to 2023. Brower has been actively involved in the American Thoracic Society. He served on the Program Committee of the Pulmonary Circulation Assembly and chaired the ATS Critical Care Assembly Planning Committee for two years. He served as chair of the Critical Care Assembly from 2003-2005 and is the recipient of the Critical Care Lifetime Achievement Award. Brower chaired the ATS Publications Policy Committee from 2012 to 2016 and twice received the ATS Presidential Citation. Brower is an accomplished clinical educator. The Johns Hopkins Osler Medical Residency Program awarded him its annual award for outstanding teaching twice, in 1996 and in 2015. The Johns Hopkins Pulmonary and Critical Care Medicine Fellowship program awarded him its annual Fellows Teaching Award in 2009. As the former Medical Director of the Medical Intensive Care Unit at Johns Hopkins Hospital, Brower focused the energy of the critical care staff to develop rigorous, evidence-based protocols and practice guidelines. He promotes standardization of care with good protocols because they help to reduce medical errors, improve the clinical research environment, and serve as effective teaching tools. Dr. Brower is rated as an Advanced provider by MediFind in Lung Transplant. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Acute Interstitial Pneumonia, Lung Transplant, and Gastrostomy. Dr. Brower is board certified in American Board Of Internal Medicine.

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Brodie is rated as an Advanced provider by MediFind in Lung Transplant. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Embolectomy, and Lung Transplant. Dr. Brodie is board certified in American Board Of Internal Medicine.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as an Advanced provider by MediFind in Lung Transplant. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant. Dr. Mathai is board certified in American Board Of Internal Medicine.

Albert Faro is a Pediatric Pulmonologist practicing medicine in Nottingham, Maryland. Dr. Faro is rated as a Distinguished provider by MediFind in Lung Transplant. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Cerebral Hypoxia, Gastroesophageal Reflux Disease (GERD), and Lung Transplant.

Dorry Segev is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Segev is rated as a Distinguished provider by MediFind in Lung Transplant. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Liver Failure, Hyperparathyroidism, Kidney Transplant, and Liver Transplant.

Michael Keller is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Keller is rated as an Advanced provider by MediFind in Lung Transplant. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Pneumonia, Acute Interstitial Pneumonia, Bronchiolitis Obliterans, Lung Metastases, and Lung Transplant.

Ananth Charya is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Charya is rated as an Advanced provider by MediFind in Lung Transplant. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Pneumonia, Interstitial Lung Disease, Bronchiolitis Obliterans, Acute Interstitial Pneumonia, and Lung Transplant.

Muhammad Qureshi is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Qureshi is rated as an Advanced provider by MediFind in Lung Transplant. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant.

Muhtadi Alnababteh is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Alnababteh is rated as an Advanced provider by MediFind in Lung Transplant. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses COVID-19, Cerebral Hypoxia, Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS), and Lung Transplant.

Dr. Yarmus is a Professor of Medicine and Oncology and the director of Interventional Pulmonology at the Johns Hopkins University School of Medicine as well as the Vice Chair of Medicine for Strategy and Finance. He is an expert in the minimally invasive diagnosis and treatment of lung cancer and he leads the Interventional Pulmonary research program at Johns Hopkins with research investigating innovative minimally invasive device development and early-stage bronchoscopic treatments. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management, pleural diseases and symptom relief with minimally invasive procedures such as indwelling pleural catheters and pleurodesis. Dr. Yarmus is a member of the Fleischner Society and a fellow of the American College of Chest Physicians and the American Thoracic Society. Dr. Yarmus is rated as an Experienced provider by MediFind in Lung Transplant. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy.

Glenn Whitman, M.D., joined the Johns Hopkins Division of Cardiac Surgery in 2009 as associate professor of surgery. His training began at the University of Pennsylvania, where he was a resident in surgery from 1979 to 1984. He then finished his general surgery training and then completed his training as a cardiothoracic surgeon at the University of Colorado. Thereafter, Dr. Whitman became an assistant professor at the University of Colorado and chief of cardiothoracic surgery at the Denver Veteran’s Administration Hospital, where he remained for two years. In 1990, he returned to his home city of Philadelphia, where he became chief of cardiac surgery at the Medical College of Pennsylvania, formerly Women’s Medical College, the first medical school in the United States to accept women. Dr. Whitman remained there for eight years before moving to the University of Maryland as chief of cardiac surgery. He has served as the director of transplantation and United Network for Organ Sharing representative at Temple University Hospital in Philadelphia, as well as its director of perioperative services, managing preadmission testing, the operating room, and the post-anesthesia care unit. In 2007, he left Temple for Thomas Jefferson Hospital, taking over the responsibilities of running the cardiac surgery intensive care unit. In summer 2009, he was returned to Baltimore to run the cardiac surgery intensive care unit and oversee the performance improvement/quality assurance program for cardiac surgery at Johns Hopkins. Dr. Whitman’s initial research interests were in cardiac ischemia-reperfusion injury and P31 nuclear magnetic resonance of cardiac bioenergetics, for which he received both National Institutes of Health and Department of Veterans Affairs funding. He has since become involved with quality outcome, and has presented at the American College of Surgeons and the Society of Thoracic Surgeons on the difficulties associated with performance improvement and quality assurance in the field of health care, particularly in the ICU. This past year, Dr. Whitman has stepped down from his role as the Chair of the Society of Thoracic Surgery Workforce on Critical Care, a role he had held since 2014. He continues to participate in the content of the Annual Meetings for the Society of Thoracic Surgery, The American Association of Thoracic Surgery, and The STS Fall Critical Care meetings as the Programmatic Co-Chair for Perioperative Care. This past year he has participated in two major consensus statements on postcardiotomy shock (see below) and low ejection fraction CABG patients (awaiting review). 2020 EACTS/ELSO/STS/AATS ExpertConsensus on Post-CardiotomyExtracorporeal Life Support in Adult Patients Ann Thorac Surg 2012;111:327-69. Dr. Whitman is rated as an Experienced provider by MediFind in Lung Transplant. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cardiogenic Shock, Compartment Syndrome, Restrictive Cardiomyopathy (RCM), Heart Bypass Surgery, and Heart Transplant. Dr. Whitman is board certified in American Board Of Thoracic Surgery.